Intestinal Microbiota Transplantation for Nonalcoholic Fatty Liver Disease (NAFLD)
Efficacy, Safety of Intestinal Microbiota Transplantation for Nonalcoholic Fatty Liver Disease
Sponsor: Zhongshan Hospital Xiamen University
Listed as NCT03648086, this NA trial focuses on Non-alcoholic Fatty Liver Disease and remains ongoing. Sponsored by Zhongshan Hospital Xiamen University, it has been updated 5 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status NA
-
Dec 2020 — Jan 2021 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Sep 2018 — Dec 2020 [monthly]
Recruiting NA
First recorded
Nov 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Zhongshan Hospital Xiamen University
For direct contact, visit the study record on ClinicalTrials.gov .